NuVasive EPS Ratio | NUVA

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio NuVasive

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
0.78	-1.24	-0.72	1.26	0.24	1.6	0.74	1.36	-0.36	0.18	0.07	-1.73	1.99	0.16	-0.77	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.99	-1.73	0.237

Quarterly EPS Ratio NuVasive

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2
0.14	-0.02	-	-0.04	-0.02	0.37	-	-0.42	0.03	-0.15	-	0.11	-0.98	0.1	0.57	0.21	0.29	0.18	0.24	0.31	0.22	-0.53	0.46	0.66	0.25	0.25	0.13	0.08	0.6	-0.18	0.23	0.26	0.21	0.66	0.16	-0.04	-0.09	-0.4	0.13	0.17	-0.15	0.02	-0.06	0.05	0.07	0.02	-0.24	-1.69	0.14	0.06	0.22	0.17

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.66	-1.69	0.0563

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
LivaNova PLC LIVN	-4.45	$ 76.43	1.81 %	$ 4.17 B	Britain
LENSAR LNSR	-2.87	$ 6.67	0.59 %	$ 79.8 M	USA
Pulmonx Corporation LUNG	-1.33	$ 1.88	2.73 %	$ 76.5 M	USA
Medtronic PLC MDT	3.75	$ 87.97	1.88 %	$ 113 B	USA
MiMedx Group MDXG	0.33	$ 4.55	0.54 %	$ 672 M	USA
Myomo MYO	-0.37	$ 1.67	2.45 %	$ 69.9 M	USA
Nano-X Imaging Ltd. NNOX	-1.16	$ 0.64	1.15 %	$ 41.5 M	Israel
InspireMD NSPR	-0.76	$ 0.58	1.64 %	$ 37.3 M	Israel
Orthofix Medical OFIX	-2.33	$ 9.5	4.51 %	$ 376 M	Curacao
Outset Medical OM	-5.37	$ 4.1	3.54 %	$ 62.4 K	USA
PAVmed PAVM	-5.63	$ 2.66	4.36 %	$ 1.78 M	USA
Penumbra PEN	4.57	$ 317.11	0.07 %	$ 12.3 B	USA
Insulet Corporation PODD	3.51	$ 135.62	2.98 %	$ 9.54 B	USA
Profound Medical Corp. PROF	1.41	$ 6.03	3.25 %	$ 182 M	Canada
Quanterix Corporation QTRX	-2.51	$ 3.81	4.67 %	$ 162 M	USA
AVITA Medical RCEL	-1.74	$ 13.25	4.17 %	$ 369 M	Australia
Sintx Technologies SINT	-6.16	$ 2.18	1.05 %	$ 6.05 M	USA
Smith & Nephew plc SNN	0.721	$ 26.92	1.87 %	$ 23.3 B	Britain
Sensus Healthcare SRTS	-0.47	$ 2.92	0.34 %	$ 47.7 M	USA
Stryker Corporation SYK	2.21	$ 285.22	3.54 %	$ 109 B	USA
Tactile Systems Technology TCMD	0.83	$ 22.47	1.67 %	$ 514 M	USA
TELA Bio TELA	-0.83	$ 1.14	0.88 %	$ 53.5 M	USA
TransMedics Group TMDX	5.6	$ 82.99	4.0 %	$ 2.82 B	USA
Tandem Diabetes Care TNDM	-0.01	$ 16.52	0.12 %	$ 1.12 B	USA
Viemed Healthcare VMD	0.38	$ 9.24	1.2 %	$ 359 M	USA
Varex Imaging Corporation VREX	-1.7	$ 18.45	0.14 %	$ 764 M	USA
Vivos Therapeutics VVOS	-2.07	$ 0.15	1.52 %	$ 1.54 M	USA
Beyond Air XAIR	-4.01	$ 2.84	0.71 %	$ 23.6 B	USA
Xtant Medical Holdings XTNT	0.04	$ 0.33	0.09 %	$ 46 M	USA
Zimmer Biomet Holdings ZBH	3.56	$ 91.57	3.72 %	$ 18.1 B	USA
Nemaura Medical NMRD	-0.57	-	-17.8 %	$ 2.74 M	Britain
Sientra SIEN	-2.23	-	-16.59 %	$ 10.3 M	USA
Silk Road Medical, Inc SILK	-1.44	-	-	$ 1.07 B	USA
Surgalign Holdings SRGA	-8.33	-	-32.98 %	$ 1.68 M	USA
ShockWave Medical SWAV	4.01	-	-	$ 12.3 B	USA
Natus Medical Incorporated NTUS	0.39	-	1.94 %	$ 1.05 B	USA
Cardiovascular Systems CSII	-0.94	-	0.15 %	$ 844 M	USA
Inari Medical NARI	-0.03	-	-	$ 4.23 B	USA
Invacare Corporation IVC	-0.54	-	-	$ 24.7 M	USA
Axonics Modulation Technologies AXNX	-0.12	-	-	$ 3.31 B	USA
ThermoGenesis Holdings THMO	-7.59	-	-25.84 %	$ 171 K	USA
Talis Biomedical Corporation TLIS	-34.1	-	3.55 %	$ 7.96 M	USA
Viveve Medical VIVE	-2.65	-	-15.35 %	$ 1.71 M	USA
ViewRay VRAY	-0.59	-	1.54 %	$ 468 M	USA
SmileDirectClub SDC	-0.71	-	-53.45 %	$ 9.71 M	USA
Acutus Medical AFIB	-0.32	-	-26.83 %	$ 2.62 M	USA
BIOLASE BIOL	-29.4	-	-13.19 %	$ 166 K	USA